Pfizer signs $3.2 billion deal with U.S. government for COVID vaccine doses

Published by

(Reuters) -Pfizer Inc and BioNTech said on Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine for delivery as soon as late summer this year. The deal also includes an Omicron-adapted vaccine, pending regulatory clearance, according to Pfizer. COVID-19 vaccine makers, including Pfizer, have been developing vaccines to target the Omicron variant that became dominant last winter, driving a massive surge in infections. The deal’s average price per dose is over $30, a more than 50% increase from the $19.50 per dose the U.S. governm…

Read More

Leave a Reply